ITFG1 inhibitors refer to a class of chemical compounds that specifically interact with the ITFG1 protein (integrin alpha FG-GAP repeat-containing protein 1) to modulate its activity. ITFG1 is a key player in various cellular processes, particularly related to the cytoskeleton and cell adhesion pathways. These inhibitors are designed to regulate the function of ITFG1 by either directly binding to its active sites or influencing associated molecular interactions that ITFG1 mediates within the cell. The ITFG1 protein contains integrin-like repeats and is thought to play a role in cellular organization and motility, possibly through its effects on integrins and other adhesion molecules. Compounds that inhibit ITFG1 may be valuable for studying how cells maintain their structural integrity, adhere to their surrounding environment, and communicate through mechanotransduction.
The development of ITFG1 inhibitors provides researchers with critical tools to dissect the molecular pathways in which this protein is involved. Since ITFG1 is implicated in intracellular signaling and possibly influences integrin-mediated adhesion, its inhibitors are valuable in studies of cell movement, polarization, and interaction with the extracellular matrix. By blocking or modulating ITFG1 activity, these inhibitors can help scientists explore how this protein contributes to the reorganization of the cytoskeleton and other key cellular processes such as migration and cellular morphology changes. The specificity of ITFG1 inhibitors allows for fine-tuned modulation of these processes, providing deeper insights into the cellular mechanisms underpinning various biological phenomena.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Integrin inhibitor that can disrupt cell adhesion and migration, processes in which ITFG1 is implicated. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II ATPase activity, can affect cell motility and contractility, thereby potentially modulating ITFG1 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that can alter cell migration and adhesion, processes in which ITFG1 is involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, can affect MAPK/ERK pathway and thereby alter ITFG1-related signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, can disrupt signaling pathways related to cell survival and migration, which could modulate ITFG1 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, can affect various signaling pathways including those related to ITFG1. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, can influence integrin-mediated signaling pathways and potentially ITFG1 function. | ||||||